PEPTIDES AND THEIR USE IN THE TREATMENT OF SKIN
    2.
    发明公开
    PEPTIDES AND THEIR USE IN THE TREATMENT OF SKIN 审中-公开
    肽及其在治疗皮肤中的用途

    公开(公告)号:EP3236981A1

    公开(公告)日:2017-11-01

    申请号:EP14908092.1

    申请日:2014-12-23

    IPC分类号: A61K38/00

    摘要: Provided are methods of diminishing the signs of aging and/or improving the health of human integuments, such as skin, and compositions useful therefor. The compositions according to the invention comprise a peptide having the sequence AECK (SEQ ID NO: 1) or a derivative thereof, in a topically acceptable vehicle.

    摘要翻译: 提供了减少老化迹象和/或改善人体皮肤如皮肤健康的方法和用于此的组合物。 根据本发明的组合物在局部可接受的载体中包含具有序列AECK(SEQ ID NO:1)或其衍生物的肽。

    TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF
    4.
    发明公开
    TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF 审中-公开
    专利组合物及其使用方法

    公开(公告)号:EP3212186A1

    公开(公告)日:2017-09-06

    申请号:EP14905127.8

    申请日:2014-10-31

    IPC分类号: A61K31/4164

    摘要: The invention is generally directed to compositions useful for improving the aesthetic appearance of human skin and the use of those compounds for improving the appearance of human skin, including improving skin tone, reducing the appearance of dark circles under the eyes, and reducing inflammation in the skin. The compositions typically comprise adrenergic receptor agonists.

    摘要翻译: 本发明一般涉及可用于改善人类皮肤的美学外观的组合物以及这些化合物用于改善人类皮肤外观的用途,包括改善肤色,减少眼睛下黑眼圈的出现,以及减少 皮肤。 该组合物通常包含肾上腺素能受体激动剂。

    TOPICAL LIGHTENING COMPOSITION AND USES THEREOF
    5.
    发明公开
    TOPICAL LIGHTENING COMPOSITION AND USES THEREOF 审中-公开
    局部用增白组合物及其用途

    公开(公告)号:EP2521558A1

    公开(公告)日:2012-11-14

    申请号:EP10841583.7

    申请日:2010-12-22

    IPC分类号: A61K31/74

    CPC分类号: A61K31/74 A61K8/46 A61Q19/02

    摘要: The disclosure relates to novel topical lightening compositions a tyrosinase inhibitor and a vehicle. There is provided a topical lightening composition comprising a 2-substituted-thio-4-substitued-4-oxobutanoic acid, ester or amide tyrosinase inhibitor, and a vehicle. The tyrosinase inhibitors of this disclosure can be used as such or as a pharmaceutically acceptable salt including conventional non-toxic salts which include a metal salt or an alkaline earth metal salt, an ammonium salt, or an organic base salt. The tyrosinase inhibitors of this disclosure can be incorporated into any cosmetically-, dermatologically-, or cosmeticatically- acceptable vehicle or carrier normally used for topical application. The compositions and methods of the disclosure are effective to lighten skin, hair, lips, and/or nails.